Monday, July 14

Hyderabad: In a major boost for postgraduate medical education in Telangana, the National Board of Examinations in Medical Sciences (NBEMS) has approved Diplomate of National Board (DNB) courses at TGSRTC Tarnaka Hospital, allocating a total of seven PG seats across three departments.


Approved Departments and Seats

Following a formal application by the Telangana State Road Transport Corporation (TGSRTC), NBEMS has sanctioned:

  • 3 seats in General Medicine
  • 2 seats in General Surgery
  • 2 seats in Orthopaedic Surgery

Admissions to the 3-year PG DNB courses will be based on NEET PG scores, while DNB-PDCET will govern admissions to the 2-year diploma programs starting from the upcoming academic year.


Improved Healthcare for RTC Staff

TGSRTC Managing Director VC Sajjanar welcomed the approval, stating it would help attract top medical professionals and significantly improve healthcare services for RTC employees. He said that Tarnaka Hospital is being upgraded into a super-specialty center, aligning with the corporation’s broader goal to offer comprehensive health services to staff.


Team Behind the Approval Recognized

The TGSRTC management congratulated the team instrumental in securing the DNB approval. Those felicitated included:

  • Medical Administrator Dr. Srinivas
  • Former OSD Dr. Saidi Reddy
  • Dr. Sushmita, Dr. Pramod Kumar, Dr. Pradeep Kumar, and Dr. Raj Kumar

They were honored in a ceremony held at Hyderabad Bus Bhavan on Monday, with top RTC officials in attendance.

Share.
Leave A Reply

Doctors Post is a news portal tailored to provide current news & updates on issues related exclusively to medical & healthcare professionals. The content of Doctor Post is judiciously authored by a dedicated team of legal experts, doctors and reporters.  The intent of the content is to expeditiously update doctor’s information & news necessary for the smooth functioning of their profession.

© 2024 Doctor Post. All Rights Reserved. Created and Maintained by Creative web Solution

Disclaimer: Use of the site is governed by our terms of use, privacy policy, and advertisement policy. For further details, please refer to our Disclaimer.

Exit mobile version